tirzepatide nash phase 3 FDA Approves First NASH Drug & Other Pipelines in Clinical Trials tirzepatide phase 3 mash FDA

Can cognitive processes be inferred from neuroimaging data

Previous work from our group supports the importance of arterial stiffness as an early-stage biomarker for future decrements in brain structure by showing that high levels of arterial stiffness in midlife, but not age-related arterial stiffening, are predictive of lower grey matter volume and greater white matter hyperintensity burden in a 10-year follow-up ( Cerebrovascular function Optimal function of cerebral conduit arteries is another critical factor in ensuring CBF matches the metabolic demands for brain function and maintain long-term brain health

Highly recommend synergy

Ms Brown Do you take this twice a day